Haemophilus b Conjugate Vaccine and CHF/AMI

• Generic Name: haemophilus b conjugate (prp-t) vaccine
• Dosage Forms: n.a.
• Other Brand Names: ActHIB, Hiberix

Haemophilus influenzae type B (Hib) is a bacteria that can cause serious illness, including breathing problems or meningitis. Hib infection usually affects children and can be fatal.

Haemophilus B conjugate (PRP-T) vaccine is used to prevent this disease in children, and is sometimes combined with vaccines to protect against other diseases. This vaccine is given to children between the ages of 2 months and 18 months old.

The vaccine works by exposing your child to a small amount of the bacteria or a protein from the bacteria, which causes the body to develop immunity to the disease. This vaccine will not treat an active infection that has already developed in the body, and will not protect against other types of influenza.

Haemophilus B conjugate vaccine is not for use in children younger than 6 weeks. When used in combination with certain diphtheria vaccines, this vaccine may not be used in children younger than 15 months.

Like any vaccine, haemophilus B conjugate vaccine may not provide protection from disease in every person.